Author:
Abdelhamid Amir Mohamed,Youssef Mahmoud E.,Abd El-Fattah Eslam E.,Gobba Naglaa A.,Gaafar Ahmed Gaafar Ahmed,Girgis Samuel,Shata Ahmed,Hafez Abdel-Moneim,El-Ahwany Eman,Amin Noha A.,Shahien Mohamed Awad,Abd-Eldayem Marwa A.,Abou-Elrous Magdy,Saber Sameh
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference72 articles.
1. Extracellular matrix and liver disease;Arriazu;Antioxid. Redox Signal.,2014
2. Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling;Khalil;Toxicol. Appl. Pharmacol.,2020
3. Nonalcoholic fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians?;Ahmed,2015
4. The therapy of idiopathic pulmonary fibrosis: what is next?;Somogyi,2019
5. Remodelling the extracellular matrix in development and disease;Bonnans;Nat. Rev. Mol. Cell Biol.,2014
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献